沙美特罗替卡松联合家庭氧疗治疗稳定期COPD临床疗效观察

Curative effect of seretide and home oxygen therapy on patients with stationary phase of chronic obstructive pulmonary disease

目的探讨沙美特罗替卡松联合家庭氧疗治疗稳定期COPD临床疗效和安全性。方法选择2010年2月～2012年2月我院呼吸内科住院治疗的36例稳定期COPD患者为研究对象,观察沙美特罗替卡松联合家庭氧疗治疗稳定期COPD临床疗效和安全性。结果治疗6个月后,患者的肺功能和血气分析均较前明显改善,差异有统计学意义(P<0.05),且未见明显的不良反应。结论沙美特罗替卡松联合家庭氧疗治疗稳定期COPD临床疗效确切,安全可靠,不良反应少,值得推广运用。

Objective To investigate the curative effect and safety of seretide and home oxygen therapy patients with stationary phase of chronic obstructive pulmonary disease. Methods The clinical data of thirty-six patients with stationary phase of chronic obstructive pulmonary disease were collected who were treated in the department of breath internal medicine in our hospital from February 2010 to February 2012, patients with stationary phase of chronic obstructive pulmonary disease were given seretide and home oxygen therapy, at last, its clinical efficacy and the incidence of adverse reactions were compared before treatment and after treatment for 6 months. Results After treatment for 6 months, lung function and blood gas analysis obviously improved （P 〈 0.05）, and there was no severe adverse reaction rate （P 〉 0.05）. Conclusion Seretide and home oxygen therapy can obtain satisfactory curative effect on patients with stationary phase of chronic obstructive pulmonary disease, it is safe and reliable, it is worthy of applying for clinical.